Evidence map›Paper›PMID 40951248›Full record

ArticleCureus2025

From Mediterranean Fever to Autoimmune Hepatitis.

Inês Salvado de Carvalho, Maria João Baldo

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Inês Salvado de CarvalhoInternal Medicine, Unidade de Saúde Local da Guarda, Guarda, PRT.
Maria João BaldoInternal Medicine, Hospital Sousa Martins, Unidade de Saúde Local da Guarda, Guarda, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown etiology. It is a rare immune-mediated pathology without a typical clinical presentation and with a challenging diagnosis. The AIH has two types (types 1 and 2) that differ by the pattern of autoantibodies presented. Treatment is based on corticosteroid therapy with prednisolone, with or without azathioprine. The treatment aims to induce and maintain histological remission, improving symptoms and survival. Here, we present the case of a 72-year-old female patient admitted to the Internal Medicine Department with suspected toxic hepatitis associated with the use of cefuroxime. During hospitalization, due to lack of improvement after antibiotic discontinuation, an extensive etiological study was performed, with a diagnosis of type 1 AIH. After the histological diagnosis, she started the treatment with corticosteroids with a good therapeutic response.

Indexed as

autoantibodieselevated transaminaseshepatitis autoimmuneimmune-mediated diseaserickettsia infections

Identifiers

PMID40951248
PMCPMC12426577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.